CASE DISCUSSION
Management of Neuropathic Pain
Presented from India by Dr. Usama Hassan Saleh0
Likes
154753
Views
6,190
Shares
6,190
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Diabetic polyneuropathy is a common complication of diabetes mellitus, characterized by nerve damage throughout the body due to prolonged high blood sugar levels. Symptoms can vary widely, including numbness, tingling, burning pain, weakness, and loss of sensation, typically starting in the feet...
Case Summary
- The discussion centered on managing neuropathic pain, with a focus on orthopedic surgery cases. It was highlighted that neuropathic pain arises from nerve damage and is distinct from muscular or skeletal pain, although mixed pain is common. The chronicity of pain, divided into acute and chronic phases, influences treatment strategies. Common causes of neuropathic pain in orthopedics include nerve trauma, entrapment syndromes, radicular pain, and surgery-related complications.
Speaker Profile
Dr. Usama Hassan Saleh
Consultant Orthopedic Surgeon, Medcare Hospitals, DubaiDr. Usama Hassan Saleh is currently working as Consultant Orthopedic Surgeon at Medcare Hospitals, Dubai. He earned his medical degree in Egypt before pursuing a clinical fellowship in upper extremity surgery at the University of Toronto, Canada. Holding membership in The Royal College of Surgeons of England (MRCS UK), he furthered his expertise by completing a PhD thesis in knee surgery at Cairo University. Dr. Hassan specializes in sports injuries and arthroscopic surgery of the shoulder, knee, elbow, and wrist, with additional focus on joint replacement surgery of the knee, shoulder, and hip. With extensive training in trauma surgery, including advanced training at the University of Toronto Hospitals, he actively contributes to teaching trauma surgery to junior orthopedic surgeons in the region as an International AO Trauma Faculty.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.